You are here: Industry Insights > Innovative drugs

News List

Analysis on the Layout of Innovative Drugs in China and Globally PharmaSources/Zhulikou431
October 27, 2021
Recently, there is a saying in the pharmaceutical industry: not all innovative drugs have a future. This saying reminds me of the lyrics - wild lilies also have spring.
With Anlotinib Sold over RMB4 Billion in 2020, Which will be the Next Blockbuster of Sino Biopharmaceutical? PharmaSources/Caicai
May 31, 2021
Sino Biopharmaceutical has recently released its 2020 annual results, with total revenue of RMB23.647 billion, down 2.4% year on year, net profit attributable to the parent of RMB2.771 billion, up 0.3% year on year
Sihuan Pharmaceutical Invests in Phase I Fund of Ascendum Capital Life Technology to Expand its Strategy in Development of Innovative Drugs prnasia
October 21, 2020
On 20 October 2020, Sihuan Pharmaceutical Holdings Group Ltd. announced that its participation in the investment of Phase I Fund of Ascendum Capital Life Technology.
Global Innovative Drugs Speeding up to Enter China with the Help from Policies PharmaSources/1℃
April 17, 2019
The National Medical Products Administration (NMPA) and National Health Commission of China organized relevant experts on Mar. 28, 2019 to...
Brii Bio raises $260M to bring drugs to China biospectrumasia
May 28, 2018
Brii, which plans to combine partnerships, R&D and digital/big data, will use WuXi AppTec and WuXi biologics for development of its projects, rather than building its own facilities.
Achievements of 5 Transnational Pharmaceutical Enterprises in China! en-CPhI.cn
August 28, 2017
Greeting Key Nodes in the Transition in China, High-speed Growth being a Normal
Global Bio-medicine Proceeded in Hardship in 2016 en-cphi
February 24, 2017
The 2016 Novel Drugs Summary issued by the U.S. Food & Drug Administration (FDA) shows that FDA approved 22 new molecular entities (NDE) in total by the end of December 2016.
Aptuit and Chiesi initiate Integrated Discovery Project to identify novel compounds to treat Idiopat pharmaasia
January 18, 2017
The agreement will integrate early discovery capabilities to identify promising compounds for further pre-clinical development.

Previous page 1 2 Next page